For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
A Cigna Foundation grant to Achilles International will help determine whether running holds the key to better mental and physical development for children with autism. The Cigna Foundation today announced its $100,000 World of Difference grant to Achilles International, which has extensive anecdotal evidence showing that walking and running help people on the autism spectrum improve their emotional and physical health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7252851-cigna-foundation-achilles-international-running-autism-study-grant/
Subaru of America, Inc. today announced the completion of a Pet Travel Seat Pilot Study as part of its continued partnership with Center for Pet Safety (CPS), a registered 501(c)(3) non-profit research and consumer advocacy organization. Subaru and CPS have tested pet products most commonly used by pet parents when traveling. Phase one tested pet harnesses, phase two tested pet crates and carriers, and now, phase three has tested pet travel seats.
A pet travel seat is typically used in a vehicle to hold or elevate the pet, but does not offer full containment. The Pet Travel Seat Pilot Study found that while a pet travel seat may offer distraction prevention, it will likely not offer crash protection in the event of an accident, which could lead to injury of the pet and the human vehicle passengers. The quality of commonly available pet travel seats did not provide effective protection in a crash scenario.
Based on the scientific test evidence collected over the past four years, in part through its partnership with Subaru, CPS can now identify the safest travel options for most pets. For small dogs and cats, Center for Pet Safety recommends one of the 2015 Top Performing Carriers; for medium and large dogs either the 2015 Top Performing Crate - Gunner Kennels G1 Intermediate with 8' Tie Down Straps, or a Center for Pet Safety Certified Harness. To view top performing products and CPS Certified products, visit www.CenterforPetSafety.org.
To view the multimedia release go to:
http://www.multivu.com/players/English/7074158-subaru-cps-pet-travel-seat-study/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
For lovers of Dragons, art and story.
On the trail of dragons forgotten, an intrepid illustrator and reporter journeys from Europe through the Middle East and finally to Saigon in search of the dark caverns and mountaintop perches where the elusive winged serpents dwell. With the gift of seeing the invisible, our explorer friend records each encounter in a journal of gorgeous, fully painted artwork, capturing every majestic and fearsome visual detail of the scaly behemoths, and accompanies his findings with snippets of local lore as evidence that these hidden beasts continue to shape the world in ways we may never expect! Find out more here- http://www.dynamite.com/htmlfiles/viewProduct.html?PRO=C1606904647 Use #Lost Dragons on Twitter for a chance to win the book!
Brought to you by Dynamite Entertainment! Video by Arsenic et Boule de Gomme. Book by Elian Black'Mor, Carine-M, Jezequel. Fantasy/Comics/Graphic novel
Facing new evidence from the Food and Agriculture Organization of the United Nations (UNFAO) that world hunger continues to rise1, Kellogg today announced a new campaign that will make it easier for people to fight hunger by donating 10 foods hungry families request most, to Feeding America® food banks across the U.S.
In a world where we produce enough food for everyone, how can more than 820 million people, or one in nine, struggle with hunger?
The answer, according to Matt Knott, Feeding America President, lies in our ability to get the right foods in the hands of the people who need it most.
To view the multimedia release go to:
https://www.multivu.com/players/English/8253053-kellogg-feeding-america-digital-food-drive-world-food-day/
Created in honor of Toyota’s shift to a mobility company and its eight-year worldwide partnership with The International Olympic and Paralympic Committees, “Start Your Impossible,” Toyota’s first-ever global marketing campaign, will roll out in 27 countries at the start of and through the Olympic and Paralympic Winter Games PyeongChang 2018.
“Start Your Impossible” shares Toyota’s evolution by highlighting real-life mobility stories of Olympic and Paralympic athletes as well as everyday athletes who demonstrate the values of humility, hard work and never giving up. The campaign marks Toyota’s long-term commitment to support the creation of a more inclusive and sustainable society in which everyone can challenge their impossible through stories of determination as well as through Toyota technologies. The two creative pillars of the multi-platform global campaign include, “inspiration,” which celebrates the human spirit and product “evidence,” showcasing Toyota’s ideas for innovations that can help people move freely.
To view the multimedia release go to:
https://www.multivu.com/players/English/8271451-toyota-olympic-paralympic-games-start-your-impossible/
US Army Captain Dale Morton is a magician soldier—a “craftsman.” After a black-ops mission gone wrong, Dale is cursed by a Persian sorcerer. Major Michael Endicott, a Puritan craftsman, finds gruesome evidence that the evil Mortons have returned, and that Dale might be one of them. Meanwhile, Dale uncovers treason in the Pentagon’s highest covert ranks. As he hunts for his enemies before they can murder him, Endicott pursues Dale, divided between his duty to capture a rogue soldier and his desire to protect Dale from his would-be assassins. Together, they will discover that the demonic horrors that have corrupted American magic are not bound by family, or even death itself.
American Craftsmen by Tom Doyle find out more at http://us.macmillan.com/americancraftsmen/TomDoyle. Fantasy, Military
